Back to Search
Start Over
Binding characterization of N ‐(2‐chloro‐5‐thiomethylphenyl)‐ N ′‐(3‐[ 3 H] 3 methoxy phenyl)‐ N ′‐methylguanidine ([ 3 H] <scp>GMOM</scp> ), a non‐competitive N ‐methyl‐D‐aspartate ( <scp>NMDA</scp> ) receptor antagonist
- Source :
- Pharmacology Research & Perspectives. 7:e00458
- Publication Year :
- 2019
- Publisher :
- Wiley, 2019.
-
Abstract
- Labeled with carbon-11, N-(2-chloro-5-thiomethylphenyl)-N'-(3-methoxyphenyl)-N'-methylguanidine ([11 C]GMOM) is currently the only positron emission tomography (PET) tracer that has shown selectivity for the ion-channel site of N-methyl-D-aspartate (NMDA) receptors in human imaging studies. The present study reports on the selectivity profile and in vitro binding properties of GMOM. The compound was screened on a panel of 80 targets, and labeled with tritium ([3 H]GMOM). The binding properties of [3 H]GMOM were compared to those of the reference ion-channel ligand [3 H](+)-dizocilpine maleate ([3 H]MK-801), in a set of concentration-response, homologous and heterologous inhibition, and association kinetics assays, performed with repeatedly washed rat forebrain preparations. GMOM was at least 70-fold more selective for NMDA receptors compared to all other targets examined. In homologous inhibition and concentration-response assays, the binding of [3 H]GMOM was regulated by NMDA receptor agonists, albeit in a less prominent manner compared to [3 H]MK-801. Scatchard transformation of homologous inhibition data produced concave upward curves for [3 H]GMOM and [3 H]MK-801. The radioligands showed bi-exponential association kinetics in the presence of 100 μmol L-1 l-glutamate/30 μmol L-1 glycine. [3 H]GMOM (3 nmol L-1 and 10 nmol L-1 ) was inhibited with dual affinity by (+)-MK-801, (R,S)-ketamine and memantine, in both presence and absence of agonists. [3 H]MK-801 (2 nmol L-1 ) was inhibited in a monophasic manner by GMOM under baseline and combined agonist conditions, with an IC50 value of ~19 nmol L-1 . The non-linear Scatchard plots, biphasic inhibition by open channel blockers, and bi-exponential kinetics of [3 H]GMOM indicate a complex mechanism of interaction with the NMDA receptor ionophore. The implications for quantifying the PET signal of [11 C]GMOM are discussed.
- Subjects :
- Agonist
Stereochemistry
medicine.drug_class
Chemistry
Memantine
Ionophore
Ligand (biochemistry)
030226 pharmacology & pharmacy
03 medical and health sciences
0302 clinical medicine
Neurology
030220 oncology & carcinogenesis
Glycine
medicine
NMDA receptor
General Pharmacology, Toxicology and Pharmaceutics
Receptor
IC50
medicine.drug
Subjects
Details
- ISSN :
- 20521707
- Volume :
- 7
- Database :
- OpenAIRE
- Journal :
- Pharmacology Research & Perspectives
- Accession number :
- edsair.doi...........b0e3bb4d51ac73ad511ed2797ea22d47
- Full Text :
- https://doi.org/10.1002/prp2.458